A phase II study of single agent depsipeptide (DEP) in patients (pts) with radio-active iodine (RAI)-refractory, metastatic, thyroid carcinoma: Preliminary toxicity and efficacy experience Meeting Abstract


Authors: Su, Y. B.; Tuttle, R. M.; Fury, M.; Ghossein, R.; Singh, B.; Herman, K.; Venkatraman, E. S.; Stambuk, H.; Robbins, R.; Pfister, D. G.
Abstract Title: A phase II study of single agent depsipeptide (DEP) in patients (pts) with radio-active iodine (RAI)-refractory, metastatic, thyroid carcinoma: Preliminary toxicity and efficacy experience
Meeting Title: 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 24
Issue: 18 Suppl. Pt. 1
Meeting Dates: 2006 Jun 2-6
Meeting Location: Atlanta, GA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2006-06-01
Start Page: 293S
Language: English
ACCESSION: WOS:000239009402042
PROVIDER: wos
Notes: --- - Meeting Abstract: 5554 - 42nd Annual Meeting of the American-Society-of-Clinical-Oncology - JUN 02-06, 2006 - Atlanta, GA - S - Part 1 - "Source: Wos"
MSK Authors
  1. Venkatraman Ennapadam Seshan
    288 Seshan
  2. Yungpo Su
    16 Su
  3. Ronald A Ghossein
    302 Ghossein
  4. Bhuvanesh Singh
    207 Singh
  5. Robert M Tuttle
    362 Tuttle
  6. Richard J Robbins
    54 Robbins
  7. Hilda Stambuk
    39 Stambuk
  8. Kristin Herman
    2 Herman
  9. David G Pfister
    251 Pfister
  10. Matthew G Fury
    93 Fury